Remedium Lifecare Ltd

Remedium Lifecare Q2 FY26 Results: PAT Doubles to ₹862.34 Lakh 📈

- Q2 FY26 Profit After Tax (PAT) rose to ₹862.34 lakh, up 85.49% from Q1 FY26 (₹464.88 lakh).

- Half-year FY26 PAT reached ₹1,327 lakh, significantly higher than full-year FY24-25 PAT (₹213 lakh).

- Consolidated revenue for Q2 FY26 stood at ₹11,105.82 lakh (operations) and ₹11,431.25 lakh (total income).

- Half-year FY26 revenue from operations hit ₹22,442.39 lakh, with total income at ₹23,115.60 lakh.

- Q2 FY26 EBITDA grew 82.70% to ₹1,043.69 lakh vs. ₹571.23 lakh in Q1 FY26.

- Half-year FY26 PBT: ₹1,614.92 lakh; PAT: ₹1,327.22 lakh; EPS: ₹0.15.

- Total assets as of Sep 30, 2025: ₹1,62,318.10 lakh.

- Expanding CDMO services via global subsidiaries, including Singapore incorporation (Sep 2024).

- Strengthening specialty pharma & chemicals through operational discipline and expansion.